Novavax (NVAX) Prepaid Assets (2010 - 2026)
Novavax (NVAX) recorded quarterly Prepaid Assets of $25.7 million in Q1 2026, down 4.11% quarter-over-quarter from $26.8 million in Q4 2025, and down 63.83% on a YoY basis from $71.1 million in Q1 2025.
Novavax (NVAX) Prepaid Assets (2010 - 2026) Analysis & Trends
Novavax's Prepaid Assets history runs 17 years deep, the most recent figure standing at $25.7 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 63.83% year-over-year to $25.7 million; the TTM figure through Mar 2026 stood at $25.7 million (down 63.83% YoY), while the FY2025 annual figure was $26.8 million, down 65.69% from the prior year.
- Prepaid Assets was $25.7 million for Q1 2026 at Novavax, down from $26.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $299.3 million in Q2 2022 to a low of $25.7 million in Q1 2026.
- Historically, Prepaid Assets has averaged $139.3 million across 5 years, with a median of $152.0 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 130.6% in 2022, then tumbled 65.69% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $237.1 million in 2022, then sank by 34.33% to $155.7 million in 2023, then sank by 49.81% to $78.2 million in 2024, then sank by 65.69% to $26.8 million in 2025, then retreated by 4.11% to $25.7 million in 2026.
- The last three Prepaid Assets figures came in at $25.7 million (Q1 2026), $26.8 million (Q4 2025), and $45.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 25.71 Mn |
| Dec 31, 2025 | 26.82 Mn |
| Sep 30, 2025 | 45.53 Mn |
| Jun 30, 2025 | 59.82 Mn |
| Mar 31, 2025 | 71.10 Mn |
| Dec 31, 2024 | 78.16 Mn |
| Sep 30, 2024 | 80.00 Mn |
| Jun 30, 2024 | 102.01 Mn |
| Mar 31, 2024 | 198.92 Mn |
| Dec 31, 2023 | 155.73 Mn |
| Sep 30, 2023 | 152.02 Mn |
| Jun 30, 2023 | 192.90 Mn |
| Mar 31, 2023 | 188.71 Mn |
| Dec 31, 2022 | 237.15 Mn |
| Sep 30, 2022 | 274.52 Mn |
| Jun 30, 2022 | 299.31 Mn |
| Mar 31, 2022 | 180.16 Mn |
| Dec 31, 2021 | 164.65 Mn |
| Sep 30, 2021 | 119.05 Mn |
| Jun 30, 2021 | 162.35 Mn |